Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 40NIH 13INDUSTRY 10OTHER_GOV 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Endocrine 2CNS 2

Conditions

Breast Neoplasms 196Neoplasms 104Colorectal Neoplasms 91Stomach Neoplasms 80Uterine Cervical Neoplasms 71Carcinoma, Non-Small-Cell Lung 67Carcinoma, Hepatocellular 54Prostatic Neoplasms 48Lung Neoplasms 48Rectal Neoplasms 46Esophageal Neoplasms 39Pancreatic Neoplasms 37Colonic Neoplasms 36Ovarian Neoplasms 35Recurrence 33Head and Neck Neoplasms 33Neoplasm Metastasis 28Motor Activity 28Multiple Myeloma 27Small Cell Lung Carcinoma 26Melanoma 25Polycystic Ovary Syndrome 24Lymphoma, Non-Hodgkin 24Lymphoma 24Leukemia, Myeloid, Acute 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Pain 20Brain Neoplasms 20Nasopharyngeal Carcinoma 18Hematologic Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Paraganglioma × Clear all
NCT00188019 2015-07-23

Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers

University Hospital, Angers

Phase NA Completed
248 enrolled
CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT01373736 2011-06-15

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

Vancouver Coastal Health

Phase 3 Unknown
CNSEndocrine

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Pheochromocytoma, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡